31
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Pachydermoperiostosis with insufficient valve function of deep vein

, , , , &
Pages 147-151 | Received 25 Jan 2017, Accepted 03 Apr 2017, Published online: 25 Apr 2017

References

  • Bianchi L, Lubrano C, Carrozzo AM, et al. Pachydermoperiostosis: study of epidermal growth factor and steroid receptors. Br J Dermatol. 1995;132:128–133.
  • Castori M, Sinibaldi L, Mingarelli R, et al. Pachydermoperiostosis: an update. Clin Genet. 2005;68:477–486.
  • Lee S, Park SY, Kwon HJ, et al. Identification of the mutations in the prostaglandin transporter gene, SLCO2A1 and clinical characterization in Korean patients with pachydermoperiostosis. J Korean Med Sci. 2016;31:735–742.
  • Madruga Dias JA, Rosa RS, Perpetuo I, et al. Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation – case report and review of literature. Semin Arthritis Rheum. 2014;43:566–569.
  • Tanese K, Niizeki H, Seki A, et al. Pathological characterization of pachydermia in pachydermoperiostosis. J Dermatol. 2015;42:710–714.
  • Li ZT, Wang D, Wang S. Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene. Br J Dermatol. 2016. [Epub ahead of print]. doi: 10.1111/bjd.14480
  • Warwas S, Specker C, Jager M, et al. Arthroscopic synovectomy and radiosynoviorthesis: a treatment option for recurrent arthritis symptoms in patients with pachydermoperiostosis. Reumatismo. 2013;65:82–85.
  • Ninomiya S, Hara T, Tsurumi H, et al. Myelofibrosis successfully treated with prednisolone in a patient with pachydermoperiostosis. Intern Med. 2011;50:2207–2211.
  • Ghosn S, Uthman I, Dahdah M, et al. Treatment of pachydermoperiostosis pachydermia with botulinum toxin type A. J Am Acad Dermatol. 2010;63:1036–1041.
  • da Costa FV, de Magalhaes Souza Fialho SC, Zimmermann AF, et al. Infliximab treatment in pachydermoperiostosis: a rare disease without an effective therapeutic option. J Clin Rheumatol. 2010;16:183–184.
  • Matucci-Cerinic M, Fattorini L, Gerini G, et al. Colchicine treatment in a case of pachydermoperiostosis with acroosteolysis. Rheumatol Int. 1988;8:185–188.
  • Park YK, Kim HJ, Chung KY. Pachydermoperiostosis: trial with isotretinoin. Yonsei Med J. 1988;29:204–207.
  • Kumar S, Sidhu S, Mahajan BB. Touraine–Soulente–Golé syndrome: a rare case report and review of the literature. Ann Dermatol. 2013;25:352–355.
  • Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333–346.
  • Wegrowski Y, Gillery P, Serpier H, et al. Alteration of matrix macromolecule synthesis by fibroblasts from a patient with pachydermoperiostosis. J Invest Dermatol. 1996;106:70–74.
  • Sasaki T, Niizeki H, Shimizu A, et al. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype–genotype correlation in Japanese patients with pachydermoperiostosis. J Dermatol Sci. 2012;68:36–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.